TrialHypertension research : official journal of the Japanese Society of Hypertension2023

Efficacy and safety of sacubitril/allisartan for the treatment of primary hypertension: a phase 2 randomized, double-blind study.

Jin Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.